Overview
American Healthcare REIT Q3 net income at $55.9 mln, reflecting strong financial performance
Company's Same-Store NOI grows 16.4% yr/yr, driven by ISHC and SHOP segments
Increased full-year 2025 guidance for Same-Store NOI and NFFO per share
Outlook
Company increases full-year 2025 Same-Store NOI growth guidance to 13.0%-15.0%
Company raises full-year 2025 NFFO guidance to $1.69-$1.72 per share
Result Drivers
SAME-STORE NOI GROWTH - Driven by strong performance in SHOP and ISHC segments, with 25.3% and 21.7% growth respectively
ACQUISITION ACTIVITY - Closed approximately $210.8 mln in acquisitions during Q3, contributing to growth
REVENUE AND EXPENSE MANAGEMENT - Disciplined revenue management and proactive expense management led to occupancy gains and RevPOR growth
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Net Income
$56.64 mln
Q3 Pretax Profit
$35.55 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialized reits peer group is "buy"
Wall Street's median 12-month price target for American Healthcare REIT Inc is $47.00, about 0.2% below its November 5 closing price of $47.09
The stock recently traded at 67 times the next 12-month earnings vs. a P/E of 72 three months ago
Press Release: ID:nPn97XJCva
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)